Geschatte realtime
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
5,105 USD | +0,29% | +1,98% | -59,93% |
Vakgebied
Aantal werknemers: 18
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Donald Picker
FOU | Founder | 78 | 28-07-15 |
Walter Klemp
CEO | Chief Executive Officer | 64 | 28-07-15 |
Jonathan Foster
DFI | Director of Finance/CFO | 60 | 22-08-16 |
Chief Tech/Sci/R&D Officer | 71 | - | |
Sandra Silberman
CTO | Chief Tech/Sci/R&D Officer | 69 | 08-11-17 |
Dennis McNamara
PRN | Corporate Officer/Principal | - | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Walter Klemp
CEO | Chief Executive Officer | 64 | 28-07-15 |
Michael Cannon
BRD | Director/Board Member | 78 | 01-07-15 |
John Climaco
BRD | Director/Board Member | 55 | 24-07-17 |
Elizabeth Cermak
BRD | Director/Board Member | 66 | 02-10-20 |
Robert George
BRD | Director/Board Member | 74 | 01-07-15 |
Joy Yan
BRD | Director/Board Member | 44 | 01-03-22 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 2 227 513 | 2 123 974 ( 95,35 %) | 0 | 95,35 % |
Bedrijfsgegevens
Moleculin Biotech, Inc.
5300 Memorial Drive Suite 950
77007, Houston
+(713) 300-5160
http://www.moleculin.comSector
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-59,93% | 11,34 mln. | |
+3,97% | 106 mld. | |
+7,02% | 23,47 mld. | |
-14,69% | 21,9 mld. | |
-7,05% | 18,77 mld. | |
-38,55% | 17,85 mld. | |
-10,27% | 16,78 mld. | |
+5,68% | 14,41 mld. | |
+35,25% | 12,86 mld. | |
+323,15% | 8,78 mld. |
- Beurs
- Aandelen
- Koers MBRX
- Onderneming Moleculin Biotech, Inc.